These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

755 related items for PubMed ID: 25670202

  • 1. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.
    Rashidian J, Le Scolan E, Ji X, Zhu Q, Mulvihill MM, Nomura D, Luo K.
    Sci Signal; 2015 Feb 10; 8(363):ra14. PubMed ID: 25670202
    [Abstract] [Full Text] [Related]

  • 2. Ski regulates Smads and TAZ signaling to suppress lung cancer progression.
    Xie M, Wu X, Zhang J, Zhang J, Li X.
    Mol Carcinog; 2017 Oct 10; 56(10):2178-2189. PubMed ID: 28398634
    [Abstract] [Full Text] [Related]

  • 3. Hippo pathway effectors YAP, TAZ and TEAD are associated with EMT master regulators ZEB, Snail and with aggressive phenotype in phyllodes breast tumors.
    Akrida I, Makrygianni M, Nikou S, Mulita F, Bravou V, Papadaki H.
    Pathol Res Pract; 2024 Oct 10; 262():155551. PubMed ID: 39153238
    [Abstract] [Full Text] [Related]

  • 4. A feed forward loop enforces YAP/TAZ signaling during tumorigenesis.
    Gill MK, Christova T, Zhang YY, Gregorieff A, Zhang L, Narimatsu M, Song S, Xiong S, Couzens AL, Tong J, Krieger JR, Moran MF, Zlotta AR, van der Kwast TH, Gingras AC, Sicheri F, Wrana JL, Attisano L.
    Nat Commun; 2018 Aug 29; 9(1):3510. PubMed ID: 30158528
    [Abstract] [Full Text] [Related]

  • 5. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
    Toloczko A, Guo F, Yuen HF, Wen Q, Wood SA, Ong YS, Chan PY, Shaik AA, Gunaratne J, Dunne MJ, Hong W, Chan SW.
    Cancer Res; 2017 Sep 15; 77(18):4921-4933. PubMed ID: 28720576
    [Abstract] [Full Text] [Related]

  • 6. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
    Moroishi T, Park HW, Qin B, Chen Q, Meng Z, Plouffe SW, Taniguchi K, Yu FX, Karin M, Pan D, Guan KL.
    Genes Dev; 2015 Jun 15; 29(12):1271-84. PubMed ID: 26109050
    [Abstract] [Full Text] [Related]

  • 7. The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner.
    Shanzer M, Ricardo-Lax I, Keshet R, Reuven N, Shaul Y.
    Oncogene; 2015 Aug 06; 34(32):4190-8. PubMed ID: 25362852
    [Abstract] [Full Text] [Related]

  • 8. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
    Kemppainen K, Wentus N, Lassila T, Laiho A, Törnquist K.
    Cell Signal; 2016 Dec 06; 28(12):1894-1903. PubMed ID: 27634386
    [Abstract] [Full Text] [Related]

  • 9. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
    Lin KC, Moroishi T, Meng Z, Jeong HS, Plouffe SW, Sekido Y, Han J, Park HW, Guan KL.
    Nat Cell Biol; 2017 Jul 28; 19(8):996-1002. PubMed ID: 28752853
    [Abstract] [Full Text] [Related]

  • 10. Metabolic control of YAP and TAZ by the mevalonate pathway.
    Sorrentino G, Ruggeri N, Specchia V, Cordenonsi M, Mano M, Dupont S, Manfrin A, Ingallina E, Sommaggio R, Piazza S, Rosato A, Piccolo S, Del Sal G.
    Nat Cell Biol; 2014 Apr 28; 16(4):357-66. PubMed ID: 24658687
    [Abstract] [Full Text] [Related]

  • 11. SnoN Antagonizes the Hippo Kinase Complex to Promote TAZ Signaling during Breast Carcinogenesis.
    Zhu Q, Le Scolan E, Jahchan N, Ji X, Xu A, Luo K.
    Dev Cell; 2016 Jun 06; 37(5):399-412. PubMed ID: 27237790
    [Abstract] [Full Text] [Related]

  • 12. The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.
    Shanzer M, Adler J, Ricardo-Lax I, Reuven N, Shaul Y.
    Proc Natl Acad Sci U S A; 2017 Feb 14; 114(7):1678-1683. PubMed ID: 28154141
    [Abstract] [Full Text] [Related]

  • 13. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
    Landry NM, Rattan SG, Filomeno KL, Meier TW, Meier SC, Foran SJ, Meier CF, Koleini N, Fandrich RR, Kardami E, Duhamel TA, Dixon IMC.
    Basic Res Cardiol; 2021 Apr 13; 116(1):25. PubMed ID: 33847835
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. ETS (E26 transformation-specific) up-regulation of the transcriptional co-activator TAZ promotes cell migration and metastasis in prostate cancer.
    Liu CY, Yu T, Huang Y, Cui L, Hong W.
    J Biol Chem; 2017 Jun 02; 292(22):9420-9430. PubMed ID: 28408625
    [Abstract] [Full Text] [Related]

  • 16. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer.
    Jung O, Baek MJ, Wooldrik C, Johnson KR, Fisher KW, Lou J, Ricks TJ, Wen T, Best MD, Cryns VL, Anderson RA, Choi S.
    EMBO J; 2024 May 02; 43(9):1740-1769. PubMed ID: 38565949
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hippo Component TAZ Functions as a Co-repressor and Negatively Regulates ΔNp63 Transcription through TEA Domain (TEAD) Transcription Factor.
    Valencia-Sama I, Zhao Y, Lai D, Janse van Rensburg HJ, Hao Y, Yang X.
    J Biol Chem; 2015 Jul 03; 290(27):16906-17. PubMed ID: 25995450
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway.
    Mo JS, Meng Z, Kim YC, Park HW, Hansen CG, Kim S, Lim DS, Guan KL.
    Nat Cell Biol; 2015 Apr 03; 17(4):500-10. PubMed ID: 25751140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.